Table of Contents

2019-2024 Global Oncology Drugs Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Oncology Drugs Consumption 2014-2024
  • 2.1.2 Oncology Drugs Consumption CAGR by Region
• 2.2 Oncology Drugs Segment by Type
  • 2.2.1 Antimetabolite
  • 2.2.2 Alkaloid drugs
  • 2.2.3 Hormone
  • 2.2.4 Targeted drug
  • 2.2.5 Platinum-based drugs
  • 2.2.6 Other
• 2.3 Oncology Drugs Consumption by Type
  • 2.3.1 Global Oncology Drugs Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Oncology Drugs Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Oncology Drugs Sale Price by Type (2014-2019)
• 2.4 Oncology Drugs Segment by Application
  • 2.4.1 Blood Cancer
  • 2.4.2 Breast Cancer
  • 2.4.3 Gastrointestinal Cancer
  • 2.4.4 Prostate Cancer
  • 2.4.5 Respiratory/Lung Cancer
  • 2.4.6 Other
• 2.5 Oncology Drugs Consumption by Application
  • 2.5.1 Global Oncology Drugs Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Oncology Drugs Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Oncology Drugs Sale Price by Application (2014-2019)

3 Global Oncology Drugs by Players

• 3.1 Global Oncology Drugs Sales Market Share by Players
  • 3.1.1 Global Oncology Drugs Sales by Players (2017-2019)
  • 3.1.2 Global Oncology Drugs Sales Market Share by Players (2017-2019)
• 3.2 Global Oncology Drugs Revenue Market Share by Players
  • 3.2.1 Global Oncology Drugs Revenue by Players (2017-2019)
  • 3.2.2 Global Oncology Drugs Revenue Market Share by Players (2017-2019)
• 3.3 Global Oncology Drugs Sale Price by Players
• 3.4 Global Oncology Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Oncology Drugs Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Oncology Drugs Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Oncology Drugs by Regions

• 4.1 Oncology Drugs by Regions
  • 4.1.1 Global Oncology Drugs Consumption by Regions
  • 4.1.2 Global Oncology Drugs Value by Regions
• 4.2 Americas Oncology Drugs Consumption Growth
• 4.3 APAC Oncology Drugs Consumption Growth
• 4.4 Europe Oncology Drugs Consumption Growth
• 4.5 Middle East & Africa Oncology Drugs Consumption Growth

5 Americas

• 5.1 Americas Oncology Drugs Consumption by Countries
  • 5.1.1 Americas Oncology Drugs Consumption by Countries (2014-2019)
  • 5.1.2 Americas Oncology Drugs Value by Countries (2014-2019)
• 5.2 Americas Oncology Drugs Consumption by Type
• 5.3 Americas Oncology Drugs Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Oncology Drugs Consumption by Countries
  • 6.1.1 APAC Oncology Drugs Consumption by Countries (2014-2019)
  • 6.1.2 APAC Oncology Drugs Value by Countries (2014-2019)
• 6.2 APAC Oncology Drugs Consumption by Type
• 6.3 APAC Oncology Drugs Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Oncology Drugs by Countries
  • 7.1.1 Europe Oncology Drugs Consumption by Countries (2014-2019)
  • 7.1.2 Europe Oncology Drugs Value by Countries (2014-2019)
• 7.2 Europe Oncology Drugs Consumption by Type
• 7.3 Europe Oncology Drugs Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Oncology Drugs by Countries
  • 8.1.1 Middle East & Africa Oncology Drugs Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Oncology Drugs Value by Countries (2014-2019)
• 8.2 Middle East & Africa Oncology Drugs Consumption by Type
• 8.3 Middle East & Africa Oncology Drugs Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Oncology Drugs Distributors
• 10.3 Oncology Drugs Customer

11 Global Oncology Drugs Market Forecast

• 11.1 Global Oncology Drugs Consumption Forecast (2019-2024)
• 11.2 Global Oncology Drugs Forecast by Regions
  • 11.2.1 Global Oncology Drugs Forecast by Regions (2019-2024)
  • 11.2.2 Global Oncology Drugs Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Oncology Drugs Forecast by Type
• 11.8 Global Oncology Drugs Forecast by Application

12 Key Players Analysis

• 12.1 Roche
  • 12.1.1 Company Details
  • 12.1.2 Oncology Drugs Product Offered
  • 12.1.3 Roche Oncology Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Roche News
• 12.2 HENGRUI
  • 12.2.1 Company Details
  • 12.2.2 Oncology Drugs Product Offered
  • 12.2.3 HENGRUI Oncology Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 HENGRUI News
• 12.3 AstraZeneca
  • 12.3.1 Company Details
  • 12.3.2 Oncology Drugs Product Offered
  • 12.3.3 AstraZeneca Oncology Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 AstraZeneca News
• 12.4 QILU
  • 12.4.1 Company Details
  • 12.4.2 Oncology Drugs Product Offered
  • 12.4.3 QILU Oncology Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 QILU News
• 12.5 Sanofi
  • 12.5.1 Company Details
  • 12.5.2 Oncology Drugs Product Offered
  • 12.5.3 Sanofi Oncology Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Sanofi News
• 12.6 HANSOH
  • 12.6.1 Company Details
  • 12.6.2 Oncology Drugs Product Offered
  • 12.6.3 HANSOH Oncology Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 HANSOH News
• 12.7 LUYE
  • 12.7.1 Company Details
  • 12.7.2 Oncology Drugs Product Offered
  • 12.7.3 LUYE Oncology Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 LUYE News
• 12.8 Novartis
  • 12.8.1 Company Details
  • 12.8.2 Oncology Drugs Product Offered
  • 12.8.3 Novartis Oncology Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Novartis News
• 12.9 GuiZhou YiBai
  • 12.9.1 Company Details
  • 12.9.2 Oncology Drugs Product Offered
  • 12.9.3 GuiZhou YiBai Oncology Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 GuiZhou YiBai News
• 12.10 Lunan
  • 12.10.1 Company Details
  • 12.10.2 Oncology Drugs Product Offered
  • 12.10.3 Lunan Oncology Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Lunan News
• 12.11 Eli Lilly and Company

13 Research Findings and Conclusion

Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
Oncology Drugs is widely used For Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Respiratory/Lung Cancer and Other Cancer Treatment. The most proportion of Oncology Drugs used for Blood Cancer and the proportion in 2017 is 22.74%.

According to this study, over the next five years the Oncology Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Oncology Drugs business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Drugs market by product type, application, key manufacturers and key regions and countries.

This study considers the Oncology Drugs value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Antimetabolite
Alkaloid drugs
Hormone
Targeted drug
Platinum-based drugs
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Roche
HENGRUI
AstraZeneca
QILU
Sanofi
HANSOH
LUYE
Novartis
GuiZhou YiBai
Lunan
Eli Lilly and Company

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Oncology Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Oncology Drugs market by identifying its various subsegments.
Focuses on the key global Oncology Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Oncology Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Oncology Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.